Avalo Therapeutics, Inc. (AVTX) vs Design Therapeutics, Inc. (DSGN)
A side-by-side comparison of Avalo Therapeutics, Inc. and Design Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AVTX
Avalo Therapeutics, Inc.
$13.59HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
DSGN
Design Therapeutics, Inc.
$11.97HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — AVTX vs DSGN
growth of $100 · dividends reinvested · last 6yAVTX -99.8% (-65.4%/yr)DSGN -70.1% (-18.2%/yr)DSGN compounded faster over this window
Log scale — wide-divergence pair
AVTX DSGN
AVTX vs DSGN: by the numbers
- •DSGN is the larger company ($748M vs $714M market cap).
- •Both run net losses; DSGN's is the smaller (0.00% vs -170055.93% net margin).
Metrics side by side
Valuation
| Metric | AVTX | DSGN |
|---|---|---|
| P/S ratio | 12107.91 | N/A |
| P/B ratio | 1.59 | 3.70 |
Profitability
| Metric | AVTX | DSGN |
|---|---|---|
| Gross margin | 100.00% | 0.00% |
| Operating margin | -123601.69% | 0.00% |
| Net margin | -170055.93% | 0.00% |
| ROE | -22.36% | -35.07% |
| ROIC | -19.45% | -38.92% |
Growth (annualized)
| Metric | AVTX | DSGN |
|---|---|---|
| Revenue CAGR (5Y) | -60.88% | N/A |
| Total return CAGR (5Y) | -70.04% | -3.82% |
Frequently asked
- How have AVTX and DSGN total returns compared?
- Over the past 5 years, AVTX delivered -70.04% and DSGN delivered -3.82% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.